Introduction {#sec1}
============

1,2,3,4-Tetrahydroisoquinolines (THIQs) are important drug precursors and biologically active molecules in natural products and pharmaceuticals,^[@ref1],[@ref2]^ such as cotarnine (hemostatic agent),^[@ref3]^ anhalinine (psychomimetic),^[@ref3]^ (±)-salsolinol (an endogenous monoamine oxidase inhibitor),^[@ref4]^ (±)-armepavine (anti-HIV activity and inhibits platelet aggregation),^[@ref5]^ (±)-norlaudanosine, and (±)-xylopinine ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Therefore, the development of an efficient method for construction of THIQs is much important and significant.

![Biologically Active THIQ Alkaloids](ao0c02957_0002){#sch1}

Direct hydrogenation of isoquinolines is one of most efficient, straightforward, and powerful methods.^[@ref6]−[@ref13]^ However, hydrogenation of *N*-heterocycles is a difficult task,^[@ref14]−[@ref17]^ especially for isoquinolines, probably because of their stable aromaticity, low reactivity, and strong coordination to the catalyst. For example, Beller and co-workers reported the cobalt catalyst for hydrogenation of quinoline with 3 mol % catalyst, 3 mol % tetradentate phosphine ligand, and 10 bar H~2~ at 60 °C in 89% yield, while higher catalyst dosage (5 mol %) and temperature (150 °C) were required for isoquinoline.^[@ref18]^ The result shows that the hydrogenation of isoquinoline is much more challenging. It requires harsh conditions, which are higher catalyst loading, pressures (H~2~), and/or temperatures. However, drastic reaction conditions usually limited the substrate scope and practical utility of these methods.

In recent years, the development of transfer hydrogenation has attracted tremendous attention because of its operational simplicity, which provides a new way to avoid the use of flammable hydrogen gas.^[@ref19]−[@ref28]^ In our previous study, we for the first time applied the oxazaborolidine--BH~3~ complex in transfer hydrogenation of *N*-heteroaromatics, including quinolines, quinoxaline, acridine, and phenanthroline under mild conditions ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).^[@ref29]^ Good to excellent yields were obtained with copper(II) perchlorate hexahydrate as the catalyst. According to the literature, there are many transfer hydrogenation methods for quinolines but they are proved to be ineffective in the transfer hydrogenation of isoquinolines. In 2004, Yamaguchi and co-workers reported a Cp\*Ir complex-catalyzed transfer hydrogenation of quinolines. However, hydrogenation of isoquinolines was unsuccessful.^[@ref30]^ In 2017, Zhou and co-workers reported a silver-catalyzed biomimetic transfer hydrogenation of quinolines. Unfortunately, no reaction occurred in hydrogenation of isoquinolines.^[@ref31]^ Following our success, we attempted to hydrogenate more challenging isoquinoline substrates, aiming to expand the substrate scope for copper-catalyzed transfer hydrogenation with the oxazaborolidine complex. To the best of our knowledge, there are only a few reports on the transfer hydrogenation of isoquinolines in detail. For example, in 2006, Deng and co-workers reported Cp\*Rh complex-catalyzed transfer hydrogenation of isoquinolinium salts (12 substrates) under mild conditions using HCOOH/Et~3~N.^[@ref32]^ In 2012, Xiao and co-workers reported the first case of transfer hydrogenation of isoquinolines (4 substrates) with \[(Cp\*RhCl~2~)~2~\]-KI in HCO~2~H/NEt~3~ azeotrope solution at 40 °C.^[@ref33]^ In 2015, Xiao and co-workers reported a iridicycle catalyst for transfer hydrogenation of isoquinolinium salt (six substrates) reflux in HCO~2~H/HCO~2~Na aqueous solution.^[@ref34]^ In 2017, Ranocchiari and co-workers reported that amino-functionalized silica-supported gold particle-catalyzed transfer hydrogenation of isoquinolines (3 substrates) with HCO~2~H/Et~3~N in DMF at 130 °C gave the N-formylated products. Then, products were deformylated with NaOH in H~2~O/EtOH at 100 °C to give the THIQs.^[@ref35]^ In other literature, only one case of transfer hydrogenation of isoquinoline was reported.^[@ref19]−[@ref28]^ They have not studied the functional group tolerance. Therefore, the search for new methods for transfer hydrogenation of isoquinolines and its derivatives under mild conditions still remains a challenging task. Herein, we reported the first example of copper-catalyzed transfer hydrogenation of isoquinolines (24 substrates) with the oxazaborolidine complex under mild reaction conditions.

![Transfer Hydrogenation of Isoquinolines](ao0c02957_0003){#sch2}

Results and Discussion {#sec2}
======================

Following our previous work, boron reagents was chosen as hydrogen source and isoquinoline **1a** was chosen as model substrate. Boron reagents were generated in situ from BH~3~·THF with various hydrogenation source precursor ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, **HSP1--7**). As shown in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, using cuprous chloride as catalyst and 1,2 amino alcohols as hydrogenation source precursor, fortunately the desired product 1,2,3,4-tetrahydroisoquinoline (**2a**) was observed in 21% yield ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 1). Subsequently, various hydrogenation source precursor, including 1,2-diols, 1,2-diamines, 1,2-diaminobenzyl alcohol, 1,2-dihydroxybenzene, and [dl]{.smallcaps}-phenylalanine were examined (entry 2--7). Surprisingly, when [dl]{.smallcaps}-phenylalanine worked as hydrogenation source precursor generated **2a** in 39% yield (entry 7). Different copper catalysts also evaluated (entry 8--13). To our delight, using copper(II) trifluoromethanesulfonate as catalyst, the catalytic activity was greatly enhanced and the yield was increased to 79% (entry 11). Furthermore, the amount of catalyst was also studied. Interestingly, the reduction of **1a** obtained product in 21% yield in the absence of catalyst. However, when the reaction was performed in the presence of 15 mol % catalyst afforded better yield (81%, entry 14). The results indicate that the amount of catalyst was very crucial for the reaction. Finally, several different solvents were tested in the reaction. Dichloroethane was the most suitable solvent and gave 85% yield (entry 19).

###### Reaction Optimization[a](#t1fn2){ref-type="table-fn"}
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  entry   metal                  metal dosage (%)   hydrogenation source precursor   solvent   yield %[b](#t1fn3){ref-type="table-fn"}
  ------- ---------------------- ------------------ -------------------------------- --------- -----------------------------------------
  1       CuCl                   20                 HSP1                             THF       21
  2       CuCl                   20                 HSP2                             THF       14
  3       CuCl                   20                 HSP3                             THF       19
  4       CuCl                   20                 HSP4                             THF       24
  5       CuCl                   20                 HSP5                             THF        
  6       CuCl                   20                 HSP6                             THF        
  7       CuCl                   20                 HSP7                             THF       39
  8       CuCl~2~                20                 HSP7                             THF       32
  9       CuI                    20                 HSP7                             THF       31
  10      Cu(ClO~4~)~2~·6H~2~O   20                 HSP7                             THF       47
  11      Cu(CF~3~SO~3~)~2~      20                 HSP7                             THF       79
  12      Cu(OAc)~2~             20                 HSP7                             THF       38
  13      CuSO~4~·5H~2~O         20                 HSP7                             THF       35
  14      Cu(CF~3~SO~3~)~2~      15                 HSP7                             THF       81
  15      Cu(CF~3~SO~3~)~2~      10                 HSP7                             THF       66
  16      Cu(CF~3~SO~3~)~2~      5                  HSP7                             THF       55
  17                                                HSP7                             THF       21
  18      Cu(CF~3~SO~3~)~2~      15                 HSP7                             DCM       61
  19      Cu(CF~3~SO~3~)~2~      15                 HSP7                             DCE       85(80)
  20      Cu(CF~3~SO~3~)~2~      15                 HSP7                             toluene   45
  21      Cu(CF~3~SO~3~)~2~      15                 HSP7                             ether     32
  22      Cu(CF~3~SO~3~)~2~      15                 HSP7                             dioxane   43

Reaction conditions: substrate (0.5 mmol), boron reagents (2.0 equiv), solvent (2.0 mL); boron reagents prepared in situ: hydrogenation source precursor (2.0 equiv), BH~3~·THF (4.0 equiv), 24 h, under Ar atmosphere.

Yields were determined by GC using *n*-hexadecane as the internal calibration standard. Isolated yields in parentheses.

With the optimized conditions in hand (15 mol % copper(II) trifluoromethanesulfonate, 2.0 equiv boron reagent with **HSP7**, 2.0 mL of DCE, rt, and 24 h), the substrate scope of isoquinolines was explored. Isoquinolines bearing nitro (**1b**) and bromo (**1c**) at the 5-position, giving the products (**2b** and **2c**) in good yields (61--76%), and keeping the nitro group intact (**2b**) are shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. The 6-position-substituted isoquinolines with electron-donating or electron-withdrawing functionalities were examined, showing the tolerance of methyl (**1d**), methoxy (**1e**), phenyl (**1f**), chloro (**1g**), and bromo (**1h**), affording the products (**2d--2h**) in good yields (76--80%). The isoquinolines bearing phenyl (**1i**), chloro (**1j**), and bromo (**1k**) at the 8-position also generate the products (**2i--2k**) in good yields (73--79%). These results imply that electronic effects of the substituents at the different positions on the aromatic ring have a minor influence on the product yields. Remarkably, more challenging substrate isoquinolines bearing substituents at the 1-position, including phenyl (**1l**), *p*-tolyl (**1m**), 4-methoxyphenyl (**1n**), naphthalene-1-yl (**1p**), 4-fluorophenyl (**1q**), and 4-(trifluoromethyl)phenyl (**1r**), were transformed to the corresponding products (**2l--2r**) in good yields (79--85%). To further explore the scope of substrates, isoquinolines containing heterocyclic substituents at the 1-position were tested, including furan-2-yl (**1s**), thiophen-2-yl (**1t**), benzofuran-2-yl (**1u**), and benzothiophen-2-yl (**1v**), providing hydrogenated products (**2s--2v**) in good yields (69--72%). These C1-substituted THIQs products (**2l**, **2n**, **2r**, and **2p**) have been studied as the key precursor of THIQ-based histone deacetylase (HDAC) inhibitors.^[@ref36]^ We speculate that hydride (the smallest group) from BH~3~, which was coordinated with the oxazaborolidine complex, was transferred to the C1 position. Therefore, the steric hindrance effect of the C1 position has no effect on the reaction. We also investigated the phenyl group on the C4 position (**1w**) for the integrity of the method and diversity of the product. The reaction proceeded readily, giving the product in good yield (79%).

###### Transfer Hydrogenation of Substituted Isoquinolines.[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}

![](ao0c02957_0008){#GRAPHIC-d7e1065-autogenerated}
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Reaction conditions: substrate (0.5 mmol), oxazaborolidine complex (2.0 equiv), Cu(CF~3~SO~3~)~2~ (0.15 equiv), DCE (2.0 mL); oxazaborolidine complex prepared in situ: HSP7 (2.0 equiv), BH~3~·THF (4.0 equiv), 24 h, under Ar atmosphere.

Isolated yield.

According to the literature and our previous work,^[@ref8],[@ref25],[@ref29],[@ref34],[@ref37]^ a plausible mechanism is proposed for the transfer hydrogenation of isoquinolines ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Initially, oxazaborolidine complex **A** is formed from BH~3~·THF with [dl]{.smallcaps}-phenylalanine in situ. Transmetalation between copper(II) trifluoromethanesulfonate and the oxazaborolidine--BH~3~ complex **A** generates the active catalytic species **B**.^[@ref37]^ Activation of isoquinoline **1a** is achieved by coordination with **B** to give the complex **C**. Subsequently, the complex C undergoes 1,2-addition to give enamine **D**, which isomerizes to 1,4-dihydroisoquinoline **E**. The dihydroisoquinoline **E** is reduced to the intermediate **G** in the same way as mentioned above. Finally, the intermediate **G** can be hydrolyzed to deliver the final product **2a**.

![Plausible Mechanism](ao0c02957_0004){#sch3}

Furthermore, we applied this methodology to the key step of synthesis of biologically active THIQs alkaloids and proved its applicability. As shown in [Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}, the reaction begins with Ru-promoted C--H activation of 6,7-dimethoxyisoquinoline **3** with 3,4-dimethoxybenzyl chloride **4**, leading to papaverine **5**.^[@ref38]^ This is followed by copper-catalyzed transfer hydrogenation with the oxazaborolidine complex under mild conditions, affording (±)-norlaudanosine **6** in good yield (62%). Moreover, (±)-norlaudanosine **6** can be transformed to (±)-laudanosine **7** or (±)-*N*-methyl-laudanosine **8** by N-methylation^[@ref39]^ and converted into (±)-xylopinine **9** by refluxing in a mixture of 35% formalin and formic acid.^[@ref40]^

![Synthesis of the Alkaloid 6 (±)-Norlaudanosine under Mild Conditions](ao0c02957_0005){#sch4}

Conclusions {#sec3}
===========

In conclusion, we have successfully expanded the use of the oxazaborolidine--BH~3~ complex in the copper-catalyzed transfer hydrogenation of isoquinolines under mild reaction conditions. A variety of isoquinolines were hydrogenated to corresponding products with good yields. This method was applied to synthesize the biologically active tetrahydrosioquinolines alkaloid (±)-norlaudanosine **6**, which is also the key precursor of (±)-laudanosine **7**, (±)-*N*-methyl-laudanosine **8**, and (±)-xylopinine **9**.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All reactions, unless otherwise specified, were using standard Schlenk techniques under an argon atmosphere. NMR spectra were recorded on a Bruker AVANCE III HD 600 spectrometer (^1^H NMR: 600 MHz. ^13^C NMR: 151 MHz) and Bruker AVANCE III HD 400 spectrometer (^1^H NMR: 400 MHz.). Chemical shifts (δ) for ^1^H NMR and ^13^C NMR spectra are given in ppm relative to the internal standard tetramethylsilane (TMS). The residual solvent signals were used as references for ^1^H NMR and ^13^C NMR spectra and the chemical shifts converted to the TMS scale (CDCl~3~: δ~H~ = 7.26 ppm. δ~C~ = 77.16 ppm). The following abbreviations in ^1^H NMR data were used to designate chemical shift multiplicities: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, and br = broad, coupling constants (*J*) in Hz.

High-resolution mass spectral (HRMS) data were recorded on a SHIMADZU LCMS-IT-TOF (Sichuan University analytical center).

The isoquinoline substrates **1f**, **1i**, and **1l--1w** were prepared from reported procedures,^[@ref41],[@ref42]^ and the rest of the isoquinolines substrates were purchased from commercial suppliers and used without further purification.

General Procedure for Copper-Catalyzed Transfer Hydrogenation of Isoquinolines {#sec4.2}
------------------------------------------------------------------------------

To a dry Schlenk tube, [dl]{.smallcaps}-Phenylalanine (1.0 mmol, 165.19 mg) and BH~3~·THF (1.0 M in THF, 2 mL, 2.0 mmol) were added at 0 °C under an argon atmosphere. The mixture was stirred for 24 h at room temperature. The oxazaborolidine complex was prepared after removing the solvent under reduced pressure. To the Schlenk tube the with oxazaborolidine complex (1.0 mmol), Cu(CF~3~SO~3~)~2~ (0.075 mmol), isoquinolines (0.5 mmol), and 1,2-dichloroethane (2.0 mL) were added under an argon atmosphere. The mixture was stirred for 24 h at room temperature and then concentrated under reduced pressure. The product was purified by silica gel column chromatography (petroleum ether/ethyl acetate, 5:1--1:2, v/v).

### 1,2,3,4-Tetrahydroisoquinoline (**2a**) {#sec4.2.1}

Shallow yellow oil (53.3 mg, yield 80%). ^1^H NMR (400 MHz, CDCl~3~): δ 7.16--7.05 (m, 3H), 7.05--6.97 (m, 1H), 4.01 (s, 2H), 3.15--3.12 (m, 2H), 2.80 (t, *J* = 6.1 Hz, 2H), 2.13 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref33]^

### 5-Nitro-1,2,3,4-tetrahydroisoquinoline (**2b**) {#sec4.2.2}

Yellow oil (54.6 mg, yield 61%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.78 (q, *J* = 3.8, 2.9 Hz, 1H), 7.42--7.00 (m, 2H), 4.10 (s, 2H), 3.14 (q, *J* = 4.3, 2.8 Hz, 2H), 3.04 (t, *J* = 5.7 Hz, 2H), 1.93 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref43]^

### 5-Bromo-1,2,3,4-tetrahydroisoquinoline (**2c**) {#sec4.2.3}

Colorless oil (80.2 mg, yield 76%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.33 (d, *J* = 7.8 Hz, 1H), 6.96--6.84 (m, 2H), 3.92 (s, 2H), 3.09 (td, *J* = 6.2, 2.1 Hz, 2H), 2.67 (t, *J* = 6.3 Hz, 2H), 1.99 (s, 1H). Analytical data were identical to those reported in the literature.^[@ref44]^

### 6-Methyl-1,2,3,4-tetrahydroisoquinoline (**2d**) {#sec4.2.4}

Shallow yellow oil (58.9 mg, yield 80%). ^1^H NMR (600 MHz, CDCl~3~): δ 6.90--6.81 (m, 3H), 3.93 (s, 2H), 3.07 (t, *J* = 6.4 Hz, 2H), 2.72 (t, *J* = 6.2 Hz, 2H), 2.22 (s, 3H). Analytical data were identical to those reported in the literature.^[@ref33]^

### 6-Methoxy-1,2,3,4-tetrahydroisoquinoline (**2e**) {#sec4.2.5}

Colorless oil (64.8 mg, yield 79%). ^1^H NMR (600 MHz, CDCl~3~): δ 6.84 (d, *J* = 8.3 Hz, 1H), 6.63 (d, *J* = 8.1 Hz, 1H), 6.54 (s, 1H), 3.88 (s, 2H), 3.70 (t, *J* = 1.7 Hz, 3H), 3.07 (m, 2H), 2.72 (t, *J* = 6.2 Hz, 2H). Analytical data were identical to those reported in the literature.^[@ref45]^

### 6-Phenyl-1,2,3,4-tetrahydroisoquinoline (**2f**) {#sec4.2.6}

Colorless oil (81.9 mg, yield 78%). ^1^H NMR (400 MHz, CDCl~3~): δ 7.59 (d, *J* = 7.3 Hz, 2H), 7.49--7.30 (m, 5H), 7.10 (d, *J* = 7.9 Hz, 1H), 4.07 (s, 2H), 3.18 (t, *J* = 6.0 Hz, 2H), 2.87 (t, *J* = 6.1 Hz, 2H), 2.10 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref46]^

### 6-Chloro-1,2,3,4-tetrahydroisoquinoline (**2g**) {#sec4.2.7}

Shallow yellow oil (64.5 mg, yield 77%). ^1^H NMR (400 MHz, CDCl~3~): δ 7.07 (d, *J* = 7.6 Hz, 2H), 6.92 (d, *J* = 8.2 Hz, 1H), 3.95 (s, 2H), 3.10 (t, *J* = 6.0 Hz, 2H), 2.75 (t, *J* = 6.0 Hz, 2H), 1.92 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref47]^

### 6-Bromo-1,2,3,4-tetrahydroisoquinoline (**2h**) {#sec4.2.8}

Colorless oil (80.8 mg, yield 76%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.16 (m, 2H), 6.80 (d, *J* = 8.3 Hz, 1H), 3.88 (s, 2H), 3.04 (t, *J* = 6.0 Hz, 2H), 2.70 (t, *J* = 6.1 Hz, 2H), 2.12 (d, *J* = 19.7 Hz, 1H). Analytical data were identical to those reported in the literature.^[@ref48]^

### 8-Phenyl-1,2,3,4-tetrahydroisoquinoline (**2i**) {#sec4.2.9}

Colorless oil (83.6 mg, yield 79%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.60--6.81 (m, 8H), 3.84 (s, 2H), 3.13 (td, *J* = 6.2, 2.0 Hz, 2H), 2.89 (t, *J* = 6.3 Hz, 2H), 1.85 (s, 1H). Analytical data were identical to those reported in the literature.^[@ref46]^

### 8-Chloro-1,2,3,4-tetrahydroisoquinoline (**2j**) {#sec4.2.10}

Shallow yellow oil (63.5 mg, yield 76%). ^1^H NMR (400 MHz, CDCl~3~): δ 7.33--6.62 (m, 3H), 4.01 (d, *J* = 5.9 Hz, 2H), 3.22--2.94 (m, 2H), 2.79 (t, *J* = 6.1 Hz, 2H), 1.80 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref49]^

### 8-Bromo-1,2,3,4-tetrahydroisoquinoline (**2k**) {#sec4.2.11}

Shallow yellow oil (77.6 mg, yield 73%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.29 (d, *J* = 7.7 Hz, 1H), 7.01--6.87 (m, 2H), 3.90 (s, 2H), 3.02 (t, *J* = 6.0 Hz, 2H), 2.72 (t, *J* = 6.0 Hz, 2H).1.92 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref50]^

### 1-Phenyl-1,2,3,4-tetrahydroisoquinoline (**2l**) {#sec4.2.12}

White solid (84.1 mg, yield 80%, mp 59--60 °C). ^1^H NMR (600 MHz, CDCl~3~): δ 7.35--7.24 (m, 5H), 7.14 (s, 2H), 7.03 (s, 1H), 6.74 (d, *J* = 7.9 Hz, 1H), 5.09 (s, 1H), 3.32--3.22 (m, 1H), 3.13--2.98 (m, 2H), 2.80--2.84 (m, 1H), 1.98 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref36]^

### 1-(*p*-Tolyl)-1,2,3,4-tetrahydroisoquinoline (**2m**) {#sec4.2.13}

White solid (88.5 mg, yield 79%, mp 68--70 °C). ^1^H NMR (600 MHz, CDCl~3~): δ 7.07--7.03 (m, 6H), 6.95--6.93 (m, 1H), 6.67 (d, *J* = 7.9 Hz, 1H), 4.98 (s, 1H), 3.19--3.16 (m, 1H), 3.06--2.87 (m, 2H), 2.80--2.62 (m, 1H), 2.25 (s, 3H), 2.04 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref51]^

### 1-(4-Methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline (**2n**) {#sec4.2.14}

White solid (97.1 mg, yield 81%, mp 84--85 °C). ^1^H NMR (600 MHz, CDCl~3~): δ 7.18 (d, *J* = 8.1 Hz, 2H), 7.13 (m, 2H), 7.03 (m, 1H), 6.85 (d, *J* = 8.1 Hz, 2H), 6.75 (d, J = 7.9 Hz, 1H), 5.05 (s, 1H), 3.79 (s, 3H), 3.26 (dt, *J* = 9.9, 4.8 Hz, 1H), 3.18--2.98 (m, 2H), 2.89--2.72 (m, 1H), 2.14 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref36]^

### 1-(\[1,1′-Biphenyl\]-4-yl)-1,2,3,4-tetrahydroisoquinoline (**2o**) {#sec4.2.15}

Colorless oil (111.7 mg, yield 78%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.57 (dd, *J* = 20.5, 7.7 Hz, 4H), 7.43 (t, *J* = 7.6 Hz, 2H), 7.34 (d, *J* = 7.6 Hz, 3H), 7.16 (d, *J* = 4.2 Hz, 2H), 7.09--7.03 (m, 1H), 6.82 (d, *J* = 7.8 Hz, 1H), 5.16 (s, 1H), 3.31--3.28 (m, 1H), 3.14--3.04 (m, 2H), 2.90--2.79 (m, 1H), 2.21 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref36]^

### 1-(Naphthalen-1-yl)-1,2,3,4-tetrahydroisoquinoline (**2p**) {#sec4.2.16}

Colorless oil (109.6 mg, yield 85%). ^1^H NMR (600 MHz, CDCl~3~): δ 8.22 (d, *J* = 7.7 Hz, 1H), 7.93--7.82 (m, 1H), 7.77 (d, *J* = 8.3 Hz, 1H), 7.49--7.42 (m, 2H), 7.36 (t, *J* = 7.7 Hz, 1H), 7.23--7.11 (m, 3H), 6.99 (t, *J* = 7.6 Hz, 1H), 6.76 (d, *J* = 7.9 Hz, 1H), 5.85 (s, 1H), 3.24 (dd, *J* = 11.7, 4.8 Hz, 1H), 3.17--3.04 (m, 2H), 2.99--2.82 (m, 1H), 2.27 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref36]^

### 1-(4-Fluorophenyl)-1,2,3,4-tetrahydroisoquinoline (**2q**) {#sec4.2.17}

White solid (91.7 mg, yield 80%, mp 87--88 °C). ^1^H NMR (600 MHz, CDCl~3~): δ 7.28--7.20 (m, 2H), 7.14 (d, *J* = 4.2 Hz, 2H), 7.08--6.94 (m, 3H), 6.71 (d, *J* = 7.7 Hz, 1H), 5.08 (s, 1H), 3.26 (m, 1H), 3.18--2.99 (m, 2H), 2.82 (m, 1H), 2.00 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref52]^

### 1-(4-(Trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline (**2r**) {#sec4.2.18}

Colorless oil (109.8 mg, yield 79%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.58 (d, *J* = 7.8 Hz, 2H), 7.39 (s, 2H), 7.16 (d, *J* = 4.1 Hz, 2H), 7.04--7.06 (m, 1H), 6.70 (d, *J* = 7.7 Hz, 1H), 5.16 (s, 1H), 3.23--3.27 (m, 1H), 3.13--3.00 (m, 2H), 2.82--2.86 (m, 1H), 2.01 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref51]^

### 1-(Furan-2-yl)-1,2,3,4-tetrahydroisoquinoline (**2s**) {#sec4.2.19}

Shallow yellow oil (71.2 mg, yield 72%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.38 (s, 1H), 7.21--7.08 (m, 3H), 7.02--7.01 (m, 1H), 6.29--6.28 (m, 1H), 5.97 (s, 1H), 5.22 (s, 1H), 3.17--3.09 (m, 1H), 3.08--3.03 (m, 1H), 2.91--2.82 (m,2H), 2.34 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref53]^

### 1-(Thiophen-2-yl)-1,2,3,4-tetrahydroisoquinoline (**2t**) {#sec4.2.20}

Shallow yellow oil (75.8 mg, yield 70%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.24 (s, 1H), 7.19--7.07 (m, 3H), 6.99 (d, *J* = 7.8 Hz, 1H), 6.95--6.93 (m, 1H), 6.89 (s, 1H), 5.41 (s, 1H), 3.28--3.24 (m, 1H), 3.12--3.08 (m, 1H), 2.97--2.92 (m, 1H), 2.86--2.81 (m, 1H), 2.23 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref54]^

### 1-(Benzofuran-2-yl)-1,2,3,4-tetrahydroisoquinoline (**2u**) {#sec4.2.21}

Colorless oil (89.5 mg, yield 72%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.45 (d, *J* = 8.0 Hz, 2H), 7.26--7.07 (m, 6H), 6.29 (s, 1H), 5.33 (s, 1H), 3.18--3.11 (m, 1H), 3.11--3.04 (m, 1H), 2.95--2.90 (m, 1H), 2.88--2.81 (m, 1H), 2.34 (br s, 1H). ^13^C NMR (151 MHz, CDCl~3~): δ 159.5, 155.1, 135.5, 134.3, 129.5, 128.2, 128.1, 127.1, 125.7, 124.1, 122.7, 120.9, 111.3, 105.9, 54.7, 40.2, 29.2. HRMS (ESI^+^): calcd for C~17~H~16~NO^+^ \[M + H\]^+^, 250.1226; found, 250.1223.

### 1-(Benzo\[*b*\]thiophen-2-yl)-1,2,3,4-tetrahydroisoquinoline (**2v**) {#sec4.2.22}

Colorless oil (96.1 mg, yield 69%). ^1^H NMR (600 MHz, CDCl~3~): δ 7.76 (d, *J* = 8.0 Hz, 1H), 7.66 (d, *J* = 7.9 Hz, 1H), 7.32--7.04 (m, 7H), 5.44 (s, 1H), 3.32--3.20 (m, 1H), 3.16--3.06 (m, 1H), 2.96--2.91 (m, 1H), 2.87--2.82 (m, 1H), 2.31 (br s, 1H). ^13^C NMR (151 MHz, CDCl~3~): δ 149.9, 140.1, 139.5, 136.6, 135.0, 129.4, 128.0, 127.0, 125.8, 124.2, 124.1, 123.4, 122.9, 122.5, 57.2, 41.1, 29.3. HRMS (EI^+^): calcd for C~17~H~15~NS \[M\], 265.0925; found, 265.0923.

### 4-Phenyl-1,2,3,4-tetrahydroisoquinoline (**2w**) {#sec4.2.23}

Colorless oil (82.7 mg, yield 79%). ^1^H NMR (400 MHz, CDCl~3~): δ 7.32--7.13 (m, 4H), 7.12--7.05 (m, 4H), 6.90 (dd, *J* = 7.3, 1.8 Hz, 1H), 4.20--4.01 (m, 3H), 3.39 (dd, *J* = 13.0, 5.3 Hz, 1H), 3.09 (dd, *J* = 13.0, 6.3 Hz, 1H), 1.90 (br s, 1H). Analytical data were identical to those reported in the literature.^[@ref55]^

### 1-(3,4-Dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (**6**) {#sec4.2.24}

Colorless oil (106.5 mg, yield 62%). ^1^H NMR (600 MHz, CDCl~3~): δ 6.79--6.70 (m, 2H), 6.69 (s, 1H), 6.59 (s, 1H), 6.52 (s, 1H), 4.10--4.04 (m, 1H), 3.84--3.73 (m, 12H), 3.23--3.02 (m, 2H), 2.82 (ddd, *J* = 24.0, 12.4, 7.4 Hz, 2H), 2.75--2.57 (m, 2H). Analytical data were identical to those reported in the literature.^[@ref56]^

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c02957](https://pubs.acs.org/doi/10.1021/acsomega.0c02957?goto=supporting-info).Optimization of reaction conditions and ^1^H NMR and ^13^C NMR spectra for all products ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c02957/suppl_file/ao0c02957_si_001.pdf))
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